Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: Potential advantages over antibodies expressed within the intracellular environment (Intrabody)-Reference-Cited by-同舟云学术

Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: Potential advantages over antibodies expressed within the intracellular environment (Intrabody)

Published:2005-01 Issue:6 Volume:64 Page:1105-1108
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Heng Boon Chin,Cao Tong

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Immunoglobulin gene rearrangement, repertoire diversity, and the allergic response;Collins;Pharmacol Ther,2003

2. Engineered antibodies take center stage;Huston;Hum Antibodies,2001

3. Engineering antibodies for clinical applications in cancer;Chester;Tumour Biol,2004

4. Passive antibody therapy for infectious diseases;Casadevall;Nat Rev Microbiol,2004

5. Catalytic antibodies: hapten design strategies and screening methods;Xu;Bioorg Med Chem,2004

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection of Functional Intracellular Nanobodies;SLAS DISCOVERY: Advancing the Science of Drug Discovery;2019-06-07

2. Antibody Delivery for Intracellular Targets: Emergent Therapeutic Potential;Bioconjugate Chemistry;2019-03-04

3. Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide;Journal of Pharmacology and Experimental Therapeutics;2019-01-14

4. Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery;BioImpacts;2017-08-23

5. Bispecifics;Methods and Principles in Medicinal Chemistry;2017-08-14